Coronavirus: WHO backs Regeneron COVID-19 drug cocktail - with equal access, price cut

Geneva, Switzerland (PANA) - The Regeneron antibody drug cocktail – casirivimab and imdevimab – has been added to the World Health Organization’s (WHO) list of treatments for COVID-19 patients, the UN agency said on Friday, before underscoring the need for lower prices and equitable distribution